Ryan K. Shields
About
Ryan K. Shields is a scholar working on Molecular Medicine, Pharmacology and Epidemiology.
According to data from OpenAlex, Ryan K. Shields has authored 199 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Molecular Medicine, 96 papers in Pharmacology and 89 papers in Epidemiology. Recurrent topics in Ryan K. Shields's work include Antibiotic Resistance in Bacteria (104 papers), Antibiotics Pharmacokinetics and Efficacy (93 papers) and Antifungal resistance and susceptibility (42 papers). Ryan K. Shields is often cited by papers focused on Antibiotic Resistance in Bacteria (104 papers), Antibiotics Pharmacokinetics and Efficacy (93 papers) and Antifungal resistance and susceptibility (42 papers). Ryan K. Shields collaborates with scholars based in United States, Japan and Spain. Ryan K. Shields's co-authors include Cornelius J. Clancy, M. Hong Nguyen, Ellen G. Press, Yohei Doi, Barry N. Kreiswirth, Liang Chen, M. Hong Nguyen, Brian A. Potoski, Binghua Hao and Shaoji Cheng and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
In The Last Decade
Ryan K. Shields
183 papers receiving 7.4k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ryan K. Shields United States | 49 | 4.7k | 3.3k | 3.1k | 2.1k | 1.6k | 199 | 7.4k | ||
| M. Hong Nguyen United States | 44 | 3.2k 0.7× | 2.3k 0.7× | 2.9k 0.9× | 2.5k 1.2× | 1.1k 0.7× | 133 | 6.3k | ||
| Jason M. Pogue United States | 42 | 3.8k 0.8× | 2.9k 0.9× | 1.9k 0.6× | 1.5k 0.7× | 1.6k 1.0× | 155 | 6.4k | ||
| Mario Tumbarello Italy | 52 | 3.8k 0.8× | 1.9k 0.6× | 3.5k 1.1× | 2.8k 1.3× | 1.7k 1.1× | 155 | 8.4k | ||
| Murat Akova Türkiye | 39 | 2.8k 0.6× | 1.6k 0.5× | 2.7k 0.9× | 2.0k 0.9× | 894 0.6× | 151 | 6.9k | ||
| George L. Daikos Greece | 40 | 4.5k 1.0× | 2.4k 0.7× | 2.1k 0.7× | 763 0.4× | 1.4k 0.9× | 136 | 6.8k | ||
| Teresa Spanu Italy | 43 | 3.5k 0.7× | 1.4k 0.4× | 2.3k 0.7× | 1.4k 0.7× | 1.4k 0.9× | 130 | 6.5k | ||
| John Quale United States | 40 | 4.7k 1.0× | 2.2k 0.7× | 1.5k 0.5× | 1.4k 0.6× | 1.4k 0.9× | 108 | 6.6k | ||
| Enrico Maria Trecarichi Italy | 38 | 2.8k 0.6× | 1.3k 0.4× | 2.3k 0.7× | 1.8k 0.9× | 1.3k 0.8× | 113 | 5.9k | ||
| Philippe Lagacé‐Wiens Canada | 38 | 2.9k 0.6× | 1.8k 0.5× | 1.7k 0.6× | 1.3k 0.6× | 922 0.6× | 126 | 5.3k | ||
| Douglas J. Biedenbach United States | 44 | 2.9k 0.6× | 1.9k 0.6× | 2.0k 0.6× | 2.2k 1.0× | 1.2k 0.7× | 153 | 6.1k |
Countries citing papers authored by Ryan K. Shields
Since
Specialization
Citations
This map shows the geographic impact of Ryan K. Shields's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan K. Shields with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan K. Shields more than expected).
Fields of papers citing papers by Ryan K. Shields
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Ryan K. Shields. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan K. Shields. The network helps show where Ryan K. Shields may publish in the future.
Co-authorship network of co-authors of Ryan K. Shields
This figure shows the co-authorship network connecting the top 25 collaborators of Ryan K. Shields. A scholar is included among the top collaborators of Ryan K. Shields based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan K. Shields. Ryan K. Shields is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Li, Yanhong, et al.. (2025). Functional Genomics of Antibiotic Susceptibility in Enterococcus faecalis From Infective Endocarditis. The Journal of Infectious Diseases. 232(5). 1108–1118.
2.
Kufel, Wesley D., Ryan K. Shields, Ellen G Kline, et al.. (2025). Pharmacokinetic and pharmacodynamic evaluation of sulbactam‐durlobactam in a critically ill patient on continuous venovenous hemofiltration infected with carbapenem‐resistant Acinetobacter baumannii‐calcoaceticus complex. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 45(7). 396–402.
3.
Shah, Sunish, Kathleen K. Adams, Lloyd Clarke, et al.. (2024). Clinical outcomes of a twice-daily metronidazole dosing strategy for Bacteroides spp. bloodstream infections. International Journal of Antimicrobial Agents. 65(3). 107403–107403.
4.
Shah, Sunish, Ellen G Kline, Ghady Haidar, et al.. (2024). Rates of Resistance to Ceftazidime-Avibactam and Ceftolozane-Tazobactam Among Patients Treated for Multidrug-Resistant Pseudomonas aeruginosa Bacteremia or Pneumonia. Clinical Infectious Diseases. 80(1). 24–28.
5.
Nordstrom, Hayley R., M. Patrick Griffith, Vatsala Rangachar Srinivasa, et al.. (2024). Harnessing the Diversity of Burkholderia spp. Prophages for Therapeutic Potential. Cells. 13(5). 428–428.
6.
Loo, Angela, et al.. (2024). Initial micafungin treatment does not improve outcomes compared to fluconazole treatment in immunocompromised and critically ill patients with candidaemia. Journal of Antimicrobial Chemotherapy. 79(8). 1877–1884.
7.
Shah, Sunish, et al.. (2023). Microbiologic and Clinical Description of Postoperative Central Nervous System Infection After Endoscopic Endonasal Surgery. World Neurosurgery. 175. e434–e438.
8.
Haidar, Ghady, Benjamin K. Chan, Shu‐Ting Cho, et al.. (2023). Phage therapy in a lung transplant recipient with cystic fibrosis infected with multidrug‐resistant Burkholderia multivorans. Transplant Infectious Disease. 25(2). e14041–e14041.
9.
Nordmann, Patrice, Ryan K. Shields, Yohei Doi, et al.. (2022). Mechanisms of Reduced Susceptibility to Cefiderocol Among Isolates from the CREDIBLE-CR and APEKS-NP Clinical Trials. Microbial Drug Resistance. 28(4). 398–407.
10.
Cheng, Shaoji, Liang Chen, Guojun Liu, et al.. (2022). Within-Host Genotypic and Phenotypic Diversity of Contemporaneous Carbapenem-Resistant Klebsiella pneumoniae from Blood Cultures of Patients with Bacteremia. mBio. 13(6). e0290622–e0290622.
11.
Evans, Daniel R., Christi L. McElheny, Alina Iovleva, et al.. (2022). Isolation and Characterization of Lytic Bacteriophages Targeting Diverse Enterobacter spp. Clinical Isolates. PubMed. 3(1). 50–58.
12.
Abdul‐Mutakabbir, Jacinda C., Juwon Yim, Kyle Stamper, et al.. (2021). In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant Acinetobacter baumannii. Antibiotics. 10(7). 880–880.
13.
Babiker, Ahmed, Daniel R. Evans, M. Patrick Griffith, et al.. (2020). Clinical and Genomic Epidemiology of Carbapenem-Nonsusceptible Citrobacter spp. at a Tertiary Health Care Center over 2 Decades. Journal of Clinical Microbiology. 58(9).
14.
Rivosecchi, Ryan, Cornelius J. Clancy, Ryan K. Shields, et al.. (2017). Effects of Isavuconazole on the Plasma Concentrations of Tacrolimus among Solid-Organ Transplant Patients. Antimicrobial Agents and Chemotherapy. 61(9).
15.
Shields, Ryan K., Liang Chen, Shaoji Cheng, et al.. (2016). Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne bla KPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections. Antimicrobial Agents and Chemotherapy. 61(3).
16.
Espinel‐Ingroff, Ana, Maiken Cavling Arendrup, Rafael Cantón, et al.. (2016). Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion Method. Antimicrobial Agents and Chemotherapy. 61(1).
17.
Eschenauer, Gregory, M. Hong Nguyen, Shmuel Shoham, et al.. (2014). Real-World Experience with Echinocandin MICs against Candida Species in a Multicenter Study of Hospitals That Routinely Perform Susceptibility Testing of Bloodstream Isolates. Antimicrobial Agents and Chemotherapy. 58(4). 1897–1906.
18.
Vergidis, Paschalis, Raymund R. Razonable, L. Joseph Wheat, et al.. (2014). Reduction in False-Positive Aspergillus Serum Galactomannan Enzyme Immunoassay Results Associated with Use of Piperacillin-Tazobactam in the United States. Journal of Clinical Microbiology. 52(6). 2199–2201.
19.
Eschenauer, Gregory, E.J. Kwak, Abhinav Humar, et al.. (2014). Targeted Versus Universal Antifungal Prophylaxis Among Liver Transplant Recipients. American Journal of Transplantation. 15(1). 180–189.
20.
Shields, Ryan K., et al.. (2013). Caspofungin MICs Correlate with Treatment Outcomes among Patients with Candida glabrata Invasive Candidiasis and Prior Echinocandin Exposure. Antimicrobial Agents and Chemotherapy. 57(8). 3528–3535.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by M. Hong Nguyen Breakdown of academic impact, for papers by Jason M. Pogue Breakdown of academic impact, for papers by Mario Tumbarello Breakdown of academic impact, for papers by Murat Akova Breakdown of academic impact, for papers by George L. Daikos Breakdown of academic impact, for papers by Teresa Spanu Breakdown of academic impact, for papers by John Quale Breakdown of academic impact, for papers by Enrico Maria Trecarichi Breakdown of academic impact, for papers by Philippe Lagacé‐Wiens Breakdown of academic impact, for papers by Douglas J. Biedenbach